Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Low vitamin D can worsen pediatric alopecia areata.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Wigs significantly improve the well-being of people with severe hair loss.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Hair absorbs different substances from solutions based on pH levels.

Different conditions affect how hair proteins assemble, and certain mutations can change their structure.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Low vitamin D levels are common in people with Alopecia Areata.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Balneophototherapy effectively treats ichthyosis linearis circumflexa but may need ongoing treatment due to short remission.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.